Efficacy and safety of cisplatin and capecitabine in combination as first line treatment for unselected patients with advanced gastric cancer

Acta Oncol. 2007;46(3):397-9. doi: 10.1080/02841860600812719.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Capecitabine
  • Cisplatin / administration & dosage
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Esophagogastric Junction / pathology
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / analogs & derivatives
  • Humans
  • Male
  • Middle Aged
  • Patient Selection
  • Stomach Neoplasms / drug therapy*
  • Survival Analysis
  • Treatment Outcome

Substances

  • Deoxycytidine
  • Capecitabine
  • Cisplatin
  • Fluorouracil